JANE STREET GROUP, LLC - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 81 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q2 2022$75,000
-1.3%
44,086
+117.7%
0.00%
Q4 2021$76,000
-90.8%
20,249
-87.3%
0.00%
Q3 2021$822,000
+213.7%
159,130
+158.3%
0.00%
Q2 2021$262,000
+43.2%
61,596
+78.5%
0.00%
Q1 2021$183,000
-64.0%
34,515
-63.5%
0.00%
Q4 2020$509,000
+0.6%
94,473
+86.7%
0.00%
Q2 2020$506,000
+201.2%
50,600
+238.5%
0.00%
Q1 2018$168,00014,9470.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q3 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 12,025,999$66,263,0002.30%
Abingworth LLP 250,000$1,375,0001.02%
Tekla Capital Management LLC 1,466,368$8,080,0000.31%
Rock Springs Capital Management LP 875,000$4,821,0000.28%
QVT Financial LP 1,360,647$6,940,0000.22%
Vident Investment Advisory, LLC 232,641$1,282,0000.13%
Hillhouse Capital Management 1,190,476$6,560,0000.13%
Orbimed Advisors 1,914,660$10,550,0000.12%
Granite Investment Partners, LLC 195,571$1,078,0000.07%
Monashee Investment Management LLC 25,000$138,0000.06%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders